{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:41:20Z","timestamp":1792669280970,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77330-5","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:25:56Z","timestamp":1790087156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-derived separation-of-function mutations reveal specific role for BRCA1 coiled coil domain in genome stability"],"prefix":"10.1038","volume":"17","author":[{"given":"Bernadett","family":"Szikriszt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayejid","family":"Hosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5502-3531","authenticated-orcid":false,"given":"Regina","family":"Martinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7668-5200","authenticated-orcid":false,"given":"Bendeg\u00faz","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1d\u00e1m","family":"P\u00f3ti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szeltner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"V\u00e1rady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Sztupinszki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5395-7509","authenticated-orcid":false,"given":"Zoltan","family":"Szallasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0544-4888","authenticated-orcid":false,"given":"Dana","family":"Branzei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5221-1094","authenticated-orcid":false,"given":"Andrea L.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-0136","authenticated-orcid":false,"given":"D\u00e1vid","family":"Sz\u00fcts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"77330_CR1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker, K. B. et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317, 2402\u20132416 https:\/\/doi.org\/10.1001\/jama.2017.7112 (2017).","journal-title":"JAMA"},{"key":"77330_CR2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jamaoncol.2022.0476","volume":"8","author":"Y Momozawa","year":"2022","unstructured":"Momozawa, Y. et al. Expansion of cancer risk profile for BRCA1 and BRCA2 pathogenic variants. JAMA Oncol. 8, 871\u2013878 https:\/\/doi.org\/10.1001\/jamaoncol.2022.0476 (2022).","journal-title":"JAMA Oncol."},{"key":"77330_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00388-9","volume":"8","author":"KN Maxwell","year":"2017","unstructured":"Maxwell, K. N. et al. BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers. Nat. Commun. 8, 319 https:\/\/doi.org\/10.1038\/s41467-017-00388-9 (2017).","journal-title":"Nat. Commun."},{"key":"77330_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4156","volume":"5","author":"KL Kanchi","year":"2014","unstructured":"Kanchi, K. L. et al. Integrated analysis of germline and somatic variants in ovarian cancer. Nat. Commun. 5, 3156 https:\/\/doi.org\/10.1038\/ncomms4156 (2014).","journal-title":"Nat. Commun."},{"key":"77330_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41580-020-0218-z","volume":"21","author":"M Tarsounas","year":"2020","unstructured":"Tarsounas, M. & Sung, P. The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication. Nat. Rev. Mol. Cell Biol. 21, 284\u2013299 https:\/\/doi.org\/10.1038\/s41580-020-0218-z (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"77330_CR6","doi-asserted-by":"publisher","first-page":"e201204005","DOI":"10.5936\/csbj.201204005","volume":"1","author":"SL Clark","year":"2012","unstructured":"Clark, S. L., Rodriguez, A. M., Snyder, R. R. & Hankins, G. D. Structure-function of the tumor suppressor BRCA1. Comput. Struct. Biotechnol. J. 1, e201204005 https:\/\/doi.org\/10.5936\/csbj.201204005 (2012).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"77330_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/ng1296-430","volume":"14","author":"LC Wu","year":"1996","unstructured":"Wu, L. C. et al. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet 14, 430\u2013440 https:\/\/doi.org\/10.1038\/ng1296-430 (1996).","journal-title":"Nat. Genet"},{"key":"77330_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nsmb.3236","volume":"23","author":"RM Densham","year":"2016","unstructured":"Densham, R. M. et al. Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection. Nat. Struct. Mol. Biol. 23, 647\u2013655 https:\/\/doi.org\/10.1038\/nsmb.3236 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77330_CR9","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1242\/jcs.105353","volume":"125","author":"JR Chapman","year":"2012","unstructured":"Chapman, J. R., Sossick, A. J., Boulton, S. J. & Jackson, S. P. BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair. J. Cell Sci. 125, 3529\u20133534 https:\/\/doi.org\/10.1242\/jcs.105353 (2012).","journal-title":"J. Cell Sci."},{"key":"77330_CR10","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1073\/pnas.111125998","volume":"98","author":"TT Paull","year":"2001","unstructured":"Paull, T. T., Cortez, D., Bowers, B., Elledge, S. J. & Gellert, M. Direct DNA binding by Brca1. Proc. Natl. Acad. Sci. USA 98, 6086\u20136091 https:\/\/doi.org\/10.1073\/pnas.111125998 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77330_CR11","doi-asserted-by":"publisher","first-page":"32863","DOI":"10.1074\/jbc.271.51.32863","volume":"271","author":"CF Chen","year":"1996","unstructured":"Chen, C. F. et al. The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J. Biol. Chem. 271, 32863\u201332868 https:\/\/doi.org\/10.1074\/jbc.271.51.32863 (1996).","journal-title":"J. Biol. Chem."},{"key":"77330_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/8743","volume":"22","author":"X Xu","year":"1999","unstructured":"Xu, X. et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat. Genet 22, 37\u201343 https:\/\/doi.org\/10.1038\/8743 (1999).","journal-title":"Nat. Genet"},{"key":"77330_CR13","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cub.2009.02.018","volume":"19","author":"F Zhang","year":"2009","unstructured":"Zhang, F. et al. PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr. Biol. 19, 524\u2013529 https:\/\/doi.org\/10.1016\/j.cub.2009.02.018 (2009).","journal-title":"Curr. Biol."},{"key":"77330_CR14","doi-asserted-by":"publisher","first-page":"7155","DOI":"10.1073\/pnas.0811159106","volume":"106","author":"SM Sy","year":"2009","unstructured":"Sy, S. M., Huen, M. S. & Chen, J. PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc. Natl. Acad. Sci. USA 106, 7155\u20137160 https:\/\/doi.org\/10.1073\/pnas.0811159106 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77330_CR15","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1158\/1541-7786.MCR-09-0123","volume":"7","author":"F Zhang","year":"2009","unstructured":"Zhang, F., Fan, Q., Ren, K. & Andreassen, P. R. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. Mol. Cancer Res 7, 1110\u20131118 https:\/\/doi.org\/10.1158\/1541-7786.MCR-09-0123 (2009).","journal-title":"Mol. Cancer Res"},{"key":"77330_CR16","doi-asserted-by":"publisher","first-page":"25388","DOI":"10.1074\/jbc.273.39.25388","volume":"273","author":"X Yu","year":"1998","unstructured":"Yu, X., Wu, L. C., Bowcock, A. M., Aronheim, A. & Baer, R. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273, 25388\u201325392 https:\/\/doi.org\/10.1074\/jbc.273.39.25388 (1998).","journal-title":"J. Biol. Chem."},{"key":"77330_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nsmb1277","volume":"14","author":"H Kim","year":"2007","unstructured":"Kim, H., Huang, J. & Chen, J. CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response. Nat. Struct. Mol. Biol. 14, 710\u2013715 https:\/\/doi.org\/10.1038\/nsmb1277 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77330_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nsmb1279","volume":"14","author":"Z Liu","year":"2007","unstructured":"Liu, Z., Wu, J. & Yu, X. CCDC98 targets BRCA1 to DNA damage sites. Nat. Struct. Mol. Biol. 14, 716\u2013720 https:\/\/doi.org\/10.1038\/nsmb1279 (2007).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77330_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1101\/gad.1381306","volume":"20","author":"RA Greenberg","year":"2006","unstructured":"Greenberg, R. A. et al. Multifactorial contributions to an acute DNA damage response by BRCA1\/BARD1-containing complexes. Genes Dev. 20, 34\u201346 https:\/\/doi.org\/10.1101\/gad.1381306 (2006).","journal-title":"Genes Dev."},{"key":"77330_CR20","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41388-024-03108-y","volume":"43","author":"S Li","year":"2024","unstructured":"Li, S. et al. Systematic investigation of BRCA1-A, -B, and -C complexes and their functions in DNA damage response and DNA repair. Oncogene 43, 2621\u20132634 https:\/\/doi.org\/10.1038\/s41388-024-03108-y (2024).","journal-title":"Oncogene"},{"key":"77330_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","volume":"1","author":"R Janavi\u010dius","year":"2010","unstructured":"Janavi\u010dius, R. Founder BRCA1\/2 mutations in Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J. 1, 397\u2013412 https:\/\/doi.org\/10.1007\/s13167-010-0037-y (2010).","journal-title":"EPMA J."},{"key":"77330_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","volume":"3","author":"SJ Ramus","year":"2009","unstructured":"Ramus, S. J. & Gayther, S. A. The contribution of BRCA1 and BRCA2 to ovarian cancer. Mol. Oncol. 3, 138\u2013150 https:\/\/doi.org\/10.1016\/j.molonc.2009.02.001 (2009).","journal-title":"Mol. Oncol."},{"key":"77330_CR23","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jama.2014.5985","volume":"313","author":"TR Rebbeck","year":"2015","unstructured":"Rebbeck, T. R. et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 313, 1347\u20131361 https:\/\/doi.org\/10.1001\/jama.2014.5985 (2015).","journal-title":"JAMA"},{"key":"77330_CR24","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1093\/hmg\/11.23.2805","volume":"11","author":"L Perrin-Vidoz","year":"2002","unstructured":"Perrin-Vidoz, L., Sinilnikova, O. M., Stoppa-Lyonnet, D., Lenoir, G. M. & Mazoyer, S. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum. Mol. Genet. 11, 2805\u20132814 https:\/\/doi.org\/10.1093\/hmg\/11.23.2805 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"77330_CR25","doi-asserted-by":"publisher","first-page":"e21350","DOI":"10.7554\/eLife.21350","volume":"6","author":"RW Anantha","year":"2017","unstructured":"Anantha, R. W. et al. Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistance. Elife 6, e21350 https:\/\/doi.org\/10.7554\/eLife.21350 (2017).","journal-title":"Elife"},{"key":"77330_CR26","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1158\/0008-5472.CAN-21-1415","volume":"81","author":"EM Pulver","year":"2021","unstructured":"Pulver, E. M. et al. A BRCA1 coiled-coil domain variant disrupting PALB2 interaction promotes the development of mammary tumors and confers a targetable defect in homologous recombination repair. Cancer Res. 81, 6171\u20136182 https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-1415 (2021).","journal-title":"Cancer Res."},{"key":"77330_CR27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917\u2013921 (2005).","journal-title":"Nature"},{"key":"77330_CR28","first-page":"100","volume":"23","author":"J Liu","year":"2025","unstructured":"Liu, J. & Matulonis, U. A. Update on PARP inhibitors for the treatment of ovarian cancer. Clin. Adv. Hematol. Oncol. 23, 100\u2013110 (2025).","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"77330_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00411-3","volume":"8","author":"N Tung","year":"2022","unstructured":"Tung, N. & Garber, J. E. PARP inhibition in breast cancer: progress made and future hopes. NPJ Breast Cancer 8, 47 https:\/\/doi.org\/10.1038\/s41523-022-00411-3 (2022).","journal-title":"NPJ Breast Cancer"},{"key":"77330_CR30","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/cancers17050756","volume":"17","author":"JH Kim","year":"2025","unstructured":"Kim, J. H. et al. The association between location of BRCA mutation and efficacy of PARP inhibitor as a frontline maintenance therapy in advanced epithelial ovarian cancer. Cancers 17, 756 https:\/\/doi.org\/10.3390\/cancers17050756 (2025).","journal-title":"Cancers"},{"key":"77330_CR31","doi-asserted-by":"publisher","first-page":"104533","DOI":"10.1016\/j.esmoop.2025.104533","volume":"10","author":"C Marchetti","year":"2025","unstructured":"Marchetti, C. et al. Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1\/2 mutation type and site: a multicenter real-world study. ESMO Open 10, 104533 https:\/\/doi.org\/10.1016\/j.esmoop.2025.104533 (2025).","journal-title":"ESMO Open"},{"key":"77330_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.annonc.2022.11.003","volume":"34","author":"SI Labidi-Galy","year":"2023","unstructured":"Labidi-Galy, S. I. et al. Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1\/ENGOT-ov25 trial subgroup exploratory analysis. Ann. Oncol. 34, 152\u2013162 https:\/\/doi.org\/10.1016\/j.annonc.2022.11.003 (2023).","journal-title":"Ann. Oncol."},{"key":"77330_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1470-2045(22)00739-2","volume":"24","author":"E Rodler","year":"2023","unstructured":"Rodler, E. et al. Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol. 24, 162\u2013174 https:\/\/doi.org\/10.1016\/S1470-2045(22)00739-2 (2023).","journal-title":"Lancet Oncol."},{"key":"77330_CR34","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1158\/1078-0432.ccr-15-2477","volume":"22","author":"ML Telli","year":"2016","unstructured":"Telli, M. L. et al. Homologous Recombination Deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer. Clin. Cancer Res. 22, 3764\u20133773 https:\/\/doi.org\/10.1158\/1078-0432.ccr-15-2477 (2016).","journal-title":"Clin. Cancer Res."},{"key":"77330_CR35","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41416-018-0274-8","volume":"119","author":"DR Hodgson","year":"2018","unstructured":"Hodgson, D. R. et al. Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes. Br. J. Cancer 119, 1401\u20131409 https:\/\/doi.org\/10.1038\/s41416-018-0274-8 (2018).","journal-title":"Br. J. Cancer"},{"key":"77330_CR36","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/onc.2016.243","volume":"36","author":"J Z\u00e1mborszky","year":"2017","unstructured":"Z\u00e1mborszky, J. et al. Loss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions. Oncogene 36, 746\u2013755 https:\/\/doi.org\/10.1038\/onc.2016.243 (2017).","journal-title":"Oncogene"},{"key":"77330_CR37","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979\u2013993 https:\/\/doi.org\/10.1016\/j.cell.2012.04.024 (2012).","journal-title":"Cell"},{"key":"77330_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 https:\/\/doi.org\/10.1038\/nature12477 (2013).","journal-title":"Nature"},{"key":"77330_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1867-0","volume":"20","author":"\u00c1 P\u00f3ti","year":"2019","unstructured":"P\u00f3ti, \u00c1 et al. Correlation of homologous recombination deficiency induced mutational signatures with sensitivity to PARP inhibitors and cytotoxic agents. Genome Biol. 20, 240 https:\/\/doi.org\/10.1186\/s13059-019-1867-0 (2019).","journal-title":"Genome Biol."},{"key":"77330_CR40","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3390\/ijms21041185","volume":"21","author":"L Hamori","year":"2020","unstructured":"Hamori, L. et al. Establishment and characterization of a Brca1\u2212\/\u2212, p53\u2212\/\u2212 mouse mammary tumor cell line. Int. J. Mol. Sci. 21, 1185 https:\/\/doi.org\/10.3390\/ijms21041185 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"77330_CR41","doi-asserted-by":"publisher","first-page":"112887","DOI":"10.1016\/j.celrep.2023.112887","volume":"42","author":"Z Gy\u00fcre","year":"2023","unstructured":"Gy\u00fcre, Z. et al. Spontaneous mutagenesis in human cells is controlled by REV1-Polymerase \u03b6 and PRIMPOL. Cell Rep. 42, 112887 https:\/\/doi.org\/10.1016\/j.celrep.2023.112887 (2023).","journal-title":"Cell Rep."},{"key":"77330_CR42","doi-asserted-by":"publisher","first-page":"W176","DOI":"10.1093\/nar\/gkae385","volume":"52","author":"G Erd\u0151s","year":"2024","unstructured":"Erd\u0151s, G. & Doszt\u00e1nyi, Z. AIUPred: combining energy estimation with deep learning for the enhanced prediction of protein disorder. Nucleic Acids Res. 52, W176\u2013W181 https:\/\/doi.org\/10.1093\/nar\/gkae385 (2024).","journal-title":"Nucleic Acids Res."},{"key":"77330_CR43","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1038\/sj.onc.1204485","volume":"20","author":"BJ Orelli","year":"2001","unstructured":"Orelli, B. J., Logsdon, J. M. & Bishop, D. K. Nine novel conserved motifs in BRCA1 identified by the chicken orthologue. Oncogene 20, 4433\u20134438 https:\/\/doi.org\/10.1038\/sj.onc.1204485 (2001).","journal-title":"Oncogene"},{"key":"77330_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27872-7","volume":"13","author":"D Chen","year":"2022","unstructured":"Chen, D. et al. BRCA1 deficiency-specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1. Nat. Commun. 13, 226 https:\/\/doi.org\/10.1038\/s41467-021-27872-7 (2022).","journal-title":"Nat. Commun."},{"key":"77330_CR45","doi-asserted-by":"publisher","first-page":"24947","DOI":"10.1073\/pnas.2011332117","volume":"117","author":"S Loeillet","year":"2020","unstructured":"Loeillet, S. et al. Trajectory and uniqueness of mutational signatures in yeast mutators. Proc. Natl. Acad. Sci. USA 117, 24947\u201324956 https:\/\/doi.org\/10.1073\/pnas.2011332117 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77330_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mrfmmm.2006.11.017","volume":"616","author":"DM Wilson","year":"2007","unstructured":"Wilson, D. M. & Thompson, L. H. Molecular mechanisms of sister-chromatid exchange. Mutat. Res. 616, 11\u201323 https:\/\/doi.org\/10.1016\/j.mrfmmm.2006.11.017 (2007).","journal-title":"Mutat. Res."},{"key":"77330_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2005.11.015","volume":"21","author":"M Lopes","year":"2006","unstructured":"Lopes, M., Foiani, M. & Sogo, J. M. Multiple mechanisms control chromosome integrity after replication fork uncoupling and restart at irreparable UV lesions. Mol. Cell 21, 15\u201327 (2006).","journal-title":"Mol. Cell"},{"key":"77330_CR48","doi-asserted-by":"publisher","first-page":"e52472","DOI":"10.1371\/journal.pone.0052472","volume":"7","author":"A Varga","year":"2012","unstructured":"Varga, A., Marcus, A. P., Himoto, M., Iwai, S. & Szuts, D. Analysis of CPD Ultraviolet Lesion Bypass in Chicken DT40 Cells: polymerase eta and PCNA Ubiquitylation Play Identical Roles. PLoS ONE 7, e52472 https:\/\/doi.org\/10.1371\/journal.pone.0052472 (2012).","journal-title":"PLoS ONE"},{"key":"77330_CR49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.dnarep.2017.04.003","volume":"54","author":"JZ Gervai","year":"2017","unstructured":"Gervai, J. Z., G\u00e1licza, J., Szeltner, Z., Z\u00e1mborszky, J. & Sz\u00fcts, D. A genetic study based on PCNA-ubiquitin fusions reveals no requirement for PCNA polyubiquitylation in DNA damage tolerance. DNA Repair (Amst.) 54, 46\u201354 https:\/\/doi.org\/10.1016\/j.dnarep.2017.04.003 (2017).","journal-title":"DNA Repair (Amst.)"},{"key":"77330_CR50","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1128\/mcb.20.11.3977-3987.2000","volume":"20","author":"D Strumberg","year":"2000","unstructured":"Strumberg, D. et al. Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5\u2019-phosphorylated DNA double-strand breaks by replication runoff. Mol. Cell Biol. 20, 3977\u20133987 https:\/\/doi.org\/10.1128\/mcb.20.11.3977-3987.2000 (2000).","journal-title":"Mol. Cell Biol."},{"key":"77330_CR51","first-page":"1169","volume":"22","author":"A Fedier","year":"2003","unstructured":"Fedier, A. et al. The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells. Int J. Oncol. 22, 1169\u20131173 (2003).","journal-title":"Int J. Oncol."},{"key":"77330_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-018-0461-z","volume":"562","author":"GM Findlay","year":"2018","unstructured":"Findlay, G. M. et al. Accurate classification of BRCA1 variants with saturation genome editing. Nature 562, 217\u2013222 https:\/\/doi.org\/10.1038\/s41586-018-0461-z (2018).","journal-title":"Nature"},{"key":"77330_CR53","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/ng.3664","volume":"48","author":"RG Lindeboom","year":"2016","unstructured":"Lindeboom, R. G., Supek, F. & Lehner, B. The rules and impact of nonsense-mediated mRNA decay in human cancers. Nat. Genet. 48, 1112\u20131118 https:\/\/doi.org\/10.1038\/ng.3664 (2016).","journal-title":"Nat. Genet."},{"key":"77330_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1097-2765(03)00281-8","volume":"12","author":"CJ Vandenberg","year":"2003","unstructured":"Vandenberg, C. J. et al. BRCA1-independent ubiquitination of FANCD2. Mol. Cell 12, 247\u2013254 (2003).","journal-title":"Mol. Cell"},{"key":"77330_CR55","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1172\/JCI87033","volume":"126","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. RING domain-deficient BRCA1 promotes PARP inhibitor and platinum resistance. J. Clin. Invest. 126, 3145\u20133157 https:\/\/doi.org\/10.1172\/JCI87033 (2016).","journal-title":"J. Clin. Invest."},{"key":"77330_CR56","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1172\/jci70196","volume":"126","author":"R Drost","year":"2016","unstructured":"Drost, R. et al. BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1. J. Clin. Invest. 126, 2903\u20132918 https:\/\/doi.org\/10.1172\/jci70196 (2016).","journal-title":"J. Clin. Invest."},{"key":"77330_CR57","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1038\/onc.2017.46","volume":"36","author":"TK Foo","year":"2017","unstructured":"Foo, T. K. et al. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk. Oncogene 36, 4161\u20134170 https:\/\/doi.org\/10.1038\/onc.2017.46 (2017).","journal-title":"Oncogene"},{"key":"77330_CR58","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1913-9","volume":"578","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Patterns of somatic structural variation in human cancer genomes. Nature 578, 112\u2013121 https:\/\/doi.org\/10.1038\/s41586-019-1913-9 (2020).","journal-title":"Nature"},{"key":"77330_CR59","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nm.4292","volume":"23","author":"H Davies","year":"2017","unstructured":"Davies, H. et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat. Med. 23, 517\u2013525 https:\/\/doi.org\/10.1038\/nm.4292 (2017).","journal-title":"Nat. Med."},{"key":"77330_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcdb.2020.07.004","volume":"113","author":"S Tye","year":"2021","unstructured":"Tye, S., Ronson, G. E. & Morris, J. R. A fork in the road: where homologous recombination and stalled replication fork protection part ways. Semin Cell Dev. Biol. 113, 14\u201326 https:\/\/doi.org\/10.1016\/j.semcdb.2020.07.004 (2021).","journal-title":"Semin Cell Dev. Biol."},{"key":"77330_CR61","doi-asserted-by":"publisher","first-page":"e1010051","DOI":"10.1371\/journal.pgen.1010051","volume":"18","author":"\u00c1 P\u00f3ti","year":"2022","unstructured":"P\u00f3ti, \u00c1, Szikriszt, B., Gervai, J. Z., Chen, D. & Sz\u00fcts, D. Characterisation of the spectrum and genetic dependence of collateral mutations induced by translesion DNA synthesis. PLoS Genet. 18, e1010051 https:\/\/doi.org\/10.1371\/journal.pgen.1010051 (2022).","journal-title":"PLoS Genet."},{"key":"77330_CR62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 https:\/\/doi.org\/10.1038\/s41586-020-1943-3 (2020).","journal-title":"Nature"},{"key":"77330_CR63","doi-asserted-by":"publisher","first-page":"8476","DOI":"10.1073\/pnas.1921791117","volume":"117","author":"J Carvajal-Garcia","year":"2020","unstructured":"Carvajal-Garcia, J. et al. Mechanistic basis for microhomology identification and genome scarring by polymerase theta. Proc. Natl. Acad. Sci. USA 117, 8476\u20138485 https:\/\/doi.org\/10.1073\/pnas.1921791117 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77330_CR64","doi-asserted-by":"publisher","first-page":"e1001205","DOI":"10.1371\/journal.pgen.1001205","volume":"6","author":"F Vanoli","year":"2010","unstructured":"Vanoli, F., Fumasoni, M., Szakal, B., Maloisel, L. & Branzei, D. Replication and recombination factors contributing to recombination-dependent bypass of DNA lesions by template switch. PLoS Genet. 6, e1001205 https:\/\/doi.org\/10.1371\/journal.pgen.1001205 (2010).","journal-title":"PLoS Genet."},{"key":"77330_CR65","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1016\/j.molcel.2025.07.003","volume":"85","author":"Y Wang","year":"2025","unstructured":"Wang, Y. et al. PALB2 and 53BP1 govern post-resection homologous recombination DNA repair. Mol. Cell 85, 2824\u20132838.e2828 https:\/\/doi.org\/10.1016\/j.molcel.2025.07.003 (2025).","journal-title":"Mol. Cell"},{"key":"77330_CR66","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1158\/0008-5472.CAN-22-1535","volume":"82","author":"TK Foo","year":"2022","unstructured":"Foo, T. K. & Xia, B. BRCA1-dependent and independent recruitment of PALB2-BRCA2-RAD51 in the DNA damage response and cancer. Cancer Res. 82, 3191\u20133197 https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1535 (2022).","journal-title":"Cancer Res."},{"key":"77330_CR67","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jmoldx.2021.04.010","volume":"23","author":"SE Brnich","year":"2021","unstructured":"Brnich, S. E., Arteaga, E. C., Wang, Y., Tan, X. & Berg, J. S. A Validated functional analysis of partner and localizer of BRCA2 missense variants for use in clinical variant interpretation. J. Mol. Diagn. 23, 847\u2013864 https:\/\/doi.org\/10.1016\/j.jmoldx.2021.04.010 (2021).","journal-title":"J. Mol. Diagn."},{"key":"77330_CR68","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1158\/2159-8290.CD-13-0094","volume":"3","author":"P Bouwman","year":"2013","unstructured":"Bouwman, P. et al. A high-throughput functional complementation assay for classification of BRCA1 missense variants. Cancer Discov. 3, 1142\u20131155 https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0094 (2013).","journal-title":"Cancer Discov."},{"key":"77330_CR69","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1021\/acs.biochem.8b00789","volume":"57","author":"F Song","year":"2018","unstructured":"Song, F. et al. Antiparallel coiled-coil interactions mediate the homodimerization of the DNA damage-repair protein PALB2. Biochemistry 57, 6581\u20136591 https:\/\/doi.org\/10.1021\/acs.biochem.8b00789 (2018).","journal-title":"Biochemistry"},{"key":"77330_CR70","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0092-8674(91)90581-I","volume":"67","author":"JM Buerstedde","year":"1991","unstructured":"Buerstedde, J. M. & Takeda, S. Increased ratio of targeted to random integration after transfection of chicken B cell lines. Cell 67, 179\u2013188 (1991).","journal-title":"Cell"},{"key":"77330_CR71","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41586-021-03776-w","volume":"596","author":"JR Becker","year":"2021","unstructured":"Becker, J. R. et al. BARD1 reads H2A lysine 15 ubiquitination to direct homologous recombination. Nature 596, 433\u2013437 https:\/\/doi.org\/10.1038\/s41586-021-03776-w (2021).","journal-title":"Nature"},{"key":"77330_CR72","doi-asserted-by":"publisher","first-page":"e53679","DOI":"10.15252\/embr.202153679","volume":"22","author":"A Sherker","year":"2021","unstructured":"Sherker, A. et al. Two redundant ubiquitin-dependent pathways of BRCA1 localization to DNA damage sites. EMBO Rep. 22, e53679 https:\/\/doi.org\/10.15252\/embr.202153679 (2021).","journal-title":"EMBO Rep."},{"key":"77330_CR73","doi-asserted-by":"publisher","first-page":"53007","DOI":"10.1074\/jbc.M310182200","volume":"278","author":"RS Williams","year":"2003","unstructured":"Williams, R. S. et al. Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations. J. Biol. Chem. 278, 53007\u201353016 https:\/\/doi.org\/10.1074\/jbc.M310182200 (2003).","journal-title":"J. Biol. Chem."},{"key":"77330_CR74","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-019-1363-4","volume":"571","author":"M Daza-Martin","year":"2019","unstructured":"Daza-Martin, M. et al. Isomerization of BRCA1-BARD1 promotes replication fork protection. Nature 571, 521\u2013527 https:\/\/doi.org\/10.1038\/s41586-019-1363-4 (2019).","journal-title":"Nature"},{"key":"77330_CR75","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.molcel.2020.04.006","volume":"78","author":"J Nacson","year":"2020","unstructured":"Nacson, J. et al. BRCA1 mutational complementation induces synthetic viability. Mol. Cell 78, 951\u2013959.e956 https:\/\/doi.org\/10.1016\/j.molcel.2020.04.006 (2020).","journal-title":"Mol. Cell"},{"key":"77330_CR76","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0022-2836(72)90418-4","volume":"66","author":"AR Lehmann","year":"1972","unstructured":"Lehmann, A. R. Postreplication repair of DNA in ultraviolet-irradiated mammalian cells. J. Mol. Biol. 66, 319\u2013337 (1972).","journal-title":"J. Mol. Biol."},{"key":"77330_CR77","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1158\/0008-5472.can-13-1443","volume":"74","author":"M Al Abo","year":"2014","unstructured":"Al Abo, M. et al. Compensatory functions and interdependency of the DNA-binding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex. Cancer Res. 74, 797\u2013807 https:\/\/doi.org\/10.1158\/0008-5472.can-13-1443 (2014).","journal-title":"Cancer Res."},{"key":"77330_CR78","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 https:\/\/doi.org\/10.1038\/nprot.2013.143 (2013).","journal-title":"Nat. Protoc."},{"key":"77330_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-1-7","volume":"1","author":"H Arakawa","year":"2001","unstructured":"Arakawa, H., Lodygin, D. & Buerstedde, J. M. Mutant loxP vectors for selectable marker recycle and conditional knock-outs. BMC Biotechnol. 1, 7 (2001).","journal-title":"BMC Biotechnol."},{"key":"77330_CR80","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 https:\/\/doi.org\/10.1093\/bioinformatics\/btu170 (2014).","journal-title":"Bioinformatics"},{"key":"77330_CR81","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 https:\/\/doi.org\/10.1093\/bioinformatics\/btp324 (2009).","journal-title":"Bioinformatics"},{"key":"77330_CR82","doi-asserted-by":"publisher","first-page":"11.10.1","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera, G. A. et al. From FastQ data to high-confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr. Protoc. Bioinformatics 43, 11.10.1\u201311.10.33 https:\/\/doi.org\/10.1002\/0471250953.bi1110s43 (2013).","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"77330_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1492-4","volume":"18","author":"O Pipek","year":"2017","unstructured":"Pipek, O. et al. Fast and accurate mutation detection in whole genome sequences of multiple isogenic samples with IsoMut. BMC Bioinforma. 18, 73 https:\/\/doi.org\/10.1186\/s12859-017-1492-4 (2017).","journal-title":"BMC Bioinforma."},{"key":"77330_CR84","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1101\/gr.222109.117","volume":"27","author":"DL Cameron","year":"2017","unstructured":"Cameron, D. L. et al. GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly. Genome Res. 27, 2050\u20132060 https:\/\/doi.org\/10.1101\/gr.222109.117 (2017).","journal-title":"Genome Res."},{"key":"77330_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08357-3","volume":"23","author":"F Manders","year":"2022","unstructured":"Manders, F. et al. MutationalPatterns: the one-stop shop for the analysis of mutational processes. BMC Genomics 23, 134 https:\/\/doi.org\/10.1186\/s12864-022-08357-3 (2022).","journal-title":"BMC Genomics"},{"key":"77330_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux, R. & Seoighe, C. A flexible R package for nonnegative matrix factorization. BMC Bioinforma. 11, 367 https:\/\/doi.org\/10.1186\/1471-2105-11-367 (2010).","journal-title":"BMC Bioinforma."},{"key":"77330_CR87","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1101\/gad.13.20.2633","volume":"13","author":"AJ Pierce","year":"1999","unstructured":"Pierce, A. J., Johnson, R. D., Thompson, L. H. & Jasin, M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev. 13, 2633\u20132638 https:\/\/doi.org\/10.1101\/gad.13.20.2633 (1999).","journal-title":"Genes Dev."},{"key":"77330_CR88","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1101\/gad.12.24.3831","volume":"12","author":"C Richardson","year":"1998","unstructured":"Richardson, C., Moynahan, M. E. & Jasin, M. Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations. Genes Dev. 12, 3831\u20133842 https:\/\/doi.org\/10.1101\/gad.12.24.3831 (1998).","journal-title":"Genes Dev."},{"key":"77330_CR89","doi-asserted-by":"publisher","first-page":"110555","DOI":"10.1016\/j.celrep.2022.110555","volume":"38","author":"RA DeWeerd","year":"2022","unstructured":"DeWeerd, R. A. et al. Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers. Cell Rep. 38, 110555 https:\/\/doi.org\/10.1016\/j.celrep.2022.110555 (2022).","journal-title":"Cell Rep."},{"key":"77330_CR90","doi-asserted-by":"publisher","first-page":"e2005970","DOI":"10.1371\/journal.pbio.2005970","volume":"16","author":"C McQuin","year":"2018","unstructured":"McQuin, C. et al. CellProfiler 3.0: Next-generation image processing for biology. PLoS Biol. 16, e2005970 https:\/\/doi.org\/10.1371\/journal.pbio.2005970 (2018).","journal-title":"PLoS Biol."},{"key":"77330_CR91","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 https:\/\/doi.org\/10.1038\/s41587-019-0201-4 (2019).","journal-title":"Nat. Biotechnol."},{"key":"77330_CR92","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general-purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 https:\/\/doi.org\/10.1093\/bioinformatics\/btt656 (2014).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77330-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77330-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77330-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:03:36Z","timestamp":1792667016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77330-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77330"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77330-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"11025"}}